Sarah McMahon

Sarah McMahon

Auto-generated profile, based on publicly available information

Sarah McMahon

Department of Molecular Genetics and Microbiology University of Florida Gainesville Florida USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
QDQiming Duan
Qiming Duan
SMSarah McMahon
Sarah McMahon
PAPriti Anand
Priti Anand
HSHirsh Shah
Hirsh Shah
STSean Thomas
Sean Thomas
SHSaptarsi M. Haldar
Saptarsi M. Haldar
BET bromodomain inhibition treats heart failure by blocking innate inflammatory and profibrotic gene networks.

1 June 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
AHAustin Hsu
Austin Hsu
QDQiming Duan
Qiming Duan
SMSarah McMahon
Sarah McMahon
YHYu Huang
Yu Huang
SWSarah A.B. Wood
Sarah A.B. Wood
SHSaptarsi M. Haldar
Saptarsi M. Haldar
Salt-inducible kinases (SIKs) are key regulators of cellular metabolism and growth, but their role in cardiomyocyte plasticity and heart failure pathogenesis remains unknown. Here, we showed that loss of SIK1 kinase activity protected against adverse cardiac remodeling and heart failure pathogenesis in rodent models and cardiomyocytes derived from human induced pluripotent stem cells. We found that SIK1 phosphorylated and stabilized histone deacetylase 7 (HDAC7) protein during cardiac stress, an event that is required for pathologic cardiomyocyte remodeling. Gain- and loss-of-function studies of HDAC7 in cultured cardiomyocytes implicated HDAC7 as a prohypertrophic signaling effector that can induce c-Myc expression, indicating a functional departure from the canonical MEF2 corepressor function of class IIa HDACs. Taken together, our findings reveal what we believe to be a previously unrecognized role for a SIK1/HDAC7 axis in regulating cardiac stress responses and implicate this pathway as a potential target in human heart failure.

11 March 2022 in Science Advances
Verified
Journal Article
Open access
ZJZhen Jiang
Zhen Jiang
SESelma Z. Elsarrag
Selma Z. Elsarrag
QDQiming Duan
Qiming Duan
ELEdward L. LaGory
Edward L. LaGory
ZWZhe Wang
Zhe Wang
SHSaptarsi M. Haldar
Saptarsi M. Haldar
Circulating corticosteroids orchestrate stress adaptation, including inhibition of inflammation. While pathways governing corticosteroid biosynthesis and intracellular signaling are well understood, less is known about mechanisms controlling plasma corticosteroid transport. Here, we show that hepatocyte KLF15 (Kruppel-like factor 15) controls plasma corticosteroid transport and inflammatory responses through direct transcriptional activation of Serpina6 , which encodes corticosteroid-binding globulin (CBG). Klf15 -deficient mice have profoundly low CBG, reduced plasma corticosteroid binding capacity, and heightened mortality during inflammatory stress. These defects are completely rescued by reconstituting CBG, supporting that KLF15 works primarily through CBG to control plasma corticosterone homeostasis. To understand transcriptional mechanisms, we generated the first KLF15 cistromes using newly engineered Klf15 3xFLAG mice. Unexpectedly, liver KLF15 is predominantly promoter enriched, including Serpina6 , where it binds a palindromic GC-rich motif, opens chromatin, and transactivates genes with minimal associated direct gene repression. Overall, we provide critical mechanistic insight into KLF15 function and identify a hepatocyte-intrinsic transcriptional module that potently regulates systemic corticosteroid transport and inflammation.

14 March 2020 in Transcription
Verified
Journal Article
Closed access
DLDanielle E Lyons
Danielle E Lyons
SMSarah McMahon
Sarah McMahon
MOMelanie Ott
Melanie Ott
The production of mRNA is a dynamic process that is highly regulated by reversible post-translational modifications of the C-terminal domain (CTD) of RNA polymerase II. The CTD is a highly repetitive domain consisting mostly of the consensus heptad sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7. Phosphorylation of serine residues within this repeat sequence is well studied, but modifications of all residues have been described. Here, we focus on integrating newly identified and lesser-studied CTD post-translational modifications into the existing framework. We also review the growing body of work demonstrating crosstalk between different CTD modifications and the functional consequences of such crosstalk on the dynamics of transcriptional regulation.

22 December 2025 in Journal of Medical Virology
Verified
Journal Article
Open access
SMSarah McMahon
Sarah McMahon
MAMaha Amer
Maha Amer
BHBrooke Hall
Brooke Hall
RSRitu Shekhar
Ritu Shekhar
Rolf RenneRolf Renne
Rolf Renne
Kaposi sarcoma‐associated herpesvirus (KSHV), a gamma‐herpesvirus, is the main etiological agent of several tumors, including Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL). The large, double‐stranded viral genome of KSHV is maintained as a latent episome in the nucleus of host cells, where a small subset of viral genes is expressed that facilitate evasion of immune responses and promotion of cell survival and proliferation supporting tumorigenesis. The major latency‐associated nuclear antigen (LANA) is an essential viral factor that is required for genome replication and segregation to maintain viral genomes within dividing cells. Given the essential role of LANA to maintain viral latency, efforts have focused on targeting LANA's role in replication and segregation as a mechanism to overcome latency and tumorigenesis. However, given the complexity in small molecule targeting to DNA‐binding domains, current efforts focused on drugging LANA continue to reach potency milestones for clinical trials. Here, we developed a HaloTag‐based PROTAC model as a proof‐of‐concept for targeted LANA protein degradation. Our findings highlight the power of a PROTAC‐based strategy on eliminating LANA and viral persistence in tissue culture demonstrating promise in the on‐going challenge for targeting this major viral factor in KSHV latency.

6 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SMSarah McMahon
Sarah McMahon
VJVaibhav Jain
Vaibhav Jain
VMViacheslav Morozov
Viacheslav Morozov
SSSunantha Sethuraman
Sunantha Sethuraman
JHJianhong Hu
Jianhong Hu
Rolf RenneRolf Renne
Rolf Renne
Kaposi's sarcoma-associated herpesvirus (KSHV), also named HHV-8, is the etiological agent of Kaposi sarcoma (KS), Primary effusion lymphoma (PEL), and Multicentric Castleman's disease. After de novo infection, KSHV genomes rapidly circularize and acquire a chromatin state that favors latency. During latency, the KSHV episome is decorated with distinct epigenetic marks that segregate the viral genome into transcriptionally active and repressed domains, enabling persistent silencing of lytic genes while retaining the capacity for reactivation. Transcription activity of chromatin is regulated at multiple levels, including the incorporation of histone variants such as H3.3, by a specific set of histone chaperones such as HIRA and DAXX. The interaction between LANA and these interphase active chaperones suggests that H3.3 deposition is a critical driver of early chromatinization and the long-term stability of KSHV latency. We detected rapid H3.3 deposition on KSHV episomes and on episomes within long-term infected cells. Moreover, we demonstrated that genetically disrupting the host H3.3 chaperone HIRA pathway by CRISPR/Cas9-mediated knockout impacted the regulation of LANA and maintenance of viral latency that was not altered in DAXX knockout cells. Collectively, these results support a role for HIRA-mediated H3.3 deposition in the regulation of KSHV latency.